ANIKA THERAPEUTICS INC (ANIK) Stock Analyst Ratings

NASDAQ:ANIK • US0352551081

10.92 USD
+0.29 (+2.73%)
At close: Feb 23, 2026
10.92 USD
0 (0%)
After Hours: 2/23/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to ANIK. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 16.32. This target is 49.45% above the current price.
  • ANIK was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ANIK.
  • In the previous month the buy percentage consensus was at a similar level.
  • ANIK was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
ANIK Historical Analyst RatingsANIK Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 10.9216.1616.3216.3216.80 - 47.99% 49.45% 49.45% 53.85%

Related screens

Find peers 30% below price target
ANIK Current Analyst RatingANIK Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2026-01-09 Barrington Research Maintains Outperform -> Outperform
2025-11-06 Barrington Research Maintains Outperform -> Outperform
2025-09-23 Barrington Research Maintains Outperform -> Outperform
2025-07-31 Barrington Research Maintains Outperform -> Outperform
2025-05-12 Barrington Research Maintains Outperform -> Outperform
2025-03-13 Barrington Research Maintains Outperform -> Outperform
2024-11-01 Barrington Research Maintains Outperform -> Outperform
2024-10-22 Barrington Research Maintains Outperform -> Outperform
2024-08-09 Barrington Research Maintains Outperform -> Outperform
2024-05-29 Stephens & Co. Reiterate Equal-Weight -> Equal-Weight
2024-05-09 Barrington Research Maintains Outperform -> Outperform
2024-03-14 Barrington Research Maintains Outperform -> Outperform
2024-03-14 Stephens & Co. Reiterate Equal-Weight -> Equal-Weight
2024-01-03 Barrington Research Maintains Outperform -> Outperform
2023-11-03 Barrington Research Maintains Outperform -> Outperform
2023-08-14 Barrington Research Upgrade Market Perform -> Outperform
2023-08-10 Stephens & Co. Maintains Equal-Weight -> Equal-Weight
2023-05-31 Stephens & Co. Reiterate Equal-Weight -> Equal-Weight
2023-04-14 Stephens & Co. Reiterate Equal-Weight
2023-03-07 Barrington Research Downgrade Outperform -> Market Perform
2022-11-09 Barrington Research Upgrade Market Perform -> Outperform
2022-10-14 Stephens & Co. Reiterate Equal-Weight
2022-03-09 Stephens & Co. Downgrade Overweight -> Equal-Weight
2021-11-16 Stephens & Co. Initiate Overweight
2021-07-16 UBS Initiate Neutral

ANIKA THERAPEUTICS INC / ANIK FAQ

Can you provide the average price target for ANIKA THERAPEUTICS INC stock?

8 analysts have analysed ANIK and the average price target is 16.32 USD. This implies a price increase of 49.45% is expected in the next year compared to the current price of 10.92.


What is the consensus rating for ANIKA THERAPEUTICS INC (ANIK) stock?

The consensus rating for ANIKA THERAPEUTICS INC (ANIK) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.


Can you provide the analyst count for ANIKA THERAPEUTICS INC stock?

The number of analysts covering ANIKA THERAPEUTICS INC (ANIK) is 8.